Department of Radiology, Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Mehmet Akif Ersoy Mah 06200, Ankara, Turkey.
Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA.
Childs Nerv Syst. 2023 Jun;39(6):1653-1656. doi: 10.1007/s00381-023-05830-6. Epub 2023 Jan 26.
Molecular diagnostics have dramatically influenced the classification of tumor groups in the 2021 WHO CNS tumor classification. Studies focusing on molecular diagnostics continue to identify new tumors. Soon after the summary of the new classification was published, "Supratentorial Neuroepithelial Tumor with PLAGL1 Fusion" was described as a distinct entity. Although this new entity is defined pathologically, its imaging features are undefined. This case report discusses the imaging findings and possible differential diagnosis of the new tumor.
分子诊断在 2021 年 WHO CNS 肿瘤分类中极大地影响了肿瘤组的分类。专注于分子诊断的研究不断发现新的肿瘤。在新分类的摘要发布后不久，“具有 PLAGL1 融合的幕上神经上皮肿瘤”被描述为一个独特的实体。尽管这个新实体在病理学上有定义，但它的影像学特征尚未确定。本病例报告讨论了新肿瘤的影像学表现和可能的鉴别诊断。
